Skip to content Skip to navigation

Looking Forward.

This will be big in the next five to 10 years if we don’t look at it now. … I don’t think stimulants have been a focus here at all.” --Stephanie Nichols, PharmD, Addiction Professional, Fall 2017
 
The opioid epidemic continues to devastate communities, straining resources for treatment and occupying the attention of law enforcement, policymakers and health professionals. While the Institute’s content continues to guide providers through this deadly crisis, we also aim to help prepare communities for the next challenges they will face in a dynamic environment.
 
A growing body of data from regions of the country, as well as words of warning from experts, point toward a brewing crisis of prescription and recreational
stimulant use that could prove especially problematic for treatment professionals. The Institute launched a number of efforts on the subject of stimulants in 2017, and we are redoubling our commitment in 2018.
 
Addiction Professional’s Fall 2017 issue cover story, “Stimulants: The Next Drug Crisis Looms,” details how a stimulant crisis could place a unique strain on communities, given the lack of treatment options specifically designed for cocaine, methamphetamine and prescription stimulant addiction. The Institute also has launched a bimonthly e-newsletter that reports on timely trends in stimulant use, including the growing prevalence of stimulants and opioids used together.
 
Our attention to the stimulant problem in 2018 will culminate with the Institute’s inaugural National Cocaine, Meth & Stimulant Summit, Nov. 12-14, 2018 in Fort Lauderdale, Fla. The event’s curriculum and diverse audience will reflect the kind of response that will be needed to generate effective solutions in communities: a partnership among law enforcement officers; clinicians in private and institutional practice; and leaders in research, prevention and public health.